Global Peptide Therapeutics Market to Value USD 25.4 Billion by 2018: Transparency Market Research

Sep 24, 2014, 12:30 ET from Transparency Market Research

ALBANY, New York, September 24, 2014 /PRNewswire/ --

Transparency Market Research has announced the addition of a new market intelligence report titled, "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," to its offering. The report articulates that the global Peptide therapeutics market, which was worth approximately 14.1 billion in 2011, is estimated to grow at an average CAGR of 8.7% and reach an approximate value of USD 25.4 billion at the end of the forecast period that ranges from 2012 to 2018.

Peptides, the polymers that contain less than 50 amino acids and have molecular weights of less than 10 KDa, represent a group of substances with unique pharmacokinetic properties as compared to small molecule drugs and large proteins.

The detailed TOC of the report can be browsed at:

Peptides are known to play essential roles in modulating cellular functions and coordinating inter-cellular communications of our bodies. Scientists say that, as peptides are made from naturally occurring, metabolically tolerable amino acids, they are usually non toxic. So, the more one can utilize peptides in the making of a drug, the safer the drug shall be.

Peptide drugs also result in a much lesser risk of side-effects because of the close relationship between peptide drug molecules and the parent molecules that they are derived from. Side-effects, if any, when occur due to peptide drugs is most commonly a case of some local reaction or a dosage related issue.  

The market for peptide drugs, which was not very developed and popular some decades back, is currently experiencing immense growth.

Get report sample PDF copy from here:

According to a recent report published by US market intelligence firm Transparency Market Research, the global market for Peptide Therapeutics, slated as being worth 14.1 billion in the year 2011, is estimated to grow at an average CAGR of 8.7% and reach a value of USD 25.4 billion by the end of 2018.

The report adds that the market growth will be driven by factors such as a global rise in incidences of metabolic and cardiovascular diseases and huge technological developments in the field of peptide manufacturing. Especially, the market is estimated to achieve good growth as a result of enhancements in technology pertaining the introduction of niche methods such as solid phase peptide syntheses and introduction of many hybrid methods that are set to provide the best of both solid and liquid syntheses.

Application wise, this market is anticipated to experience a healthy growth in cancer peptide segment while the segment of neuropeptides is also estimated to grow at a vigorous rate of an average CAGR of 9.4% during the forecasted period. This market shall achieve this growth as a result of the rising cases of neurological disorders around the globe, the report added.

Related & Recently Published Reports by Transparency Market Research 

According to the report, the segment of hybrid technology of peptide synthesis is estimated to experience the highest growth of 12.1% during the forecasted period. Though the current share of peptide drugs is only near to 1.55% of the overall medicine market, the numbers are dramatically increasing every passing year. The report estimates that currently over 120 new peptide drugs are in their clinical trial phase and some 500 to 600 are in their preclinical trial phases.

The new report on this market offered by Transparency Market Research offers a whole new outlook to the market activities, factors affecting its growth, factors restraining its growth, the various application fields of peptide drugs, the types of drugs currently available in the market, various routes of administration of drugs and the current technologies applied for manufacturing peptide drugs are discussed in detail.

Browse full Press Release of this report:

About Us: 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Sheela AK

State Tower, 90 State Street,

Suite 700, Albany NY - 12207

USA/Canada Toll Free: 866-552-3453




Browse All Categories:

Browse All Press Releases:

Browse all Articles:

SOURCE Transparency Market Research